The Hyperlipidaemic Drug Fenofibrate Significantly Reduces Infection by SARS-CoV-2 in Cell Culture Models. (2021)

First Author: Davies SP
Attributed to:  Elements of Bioremediation, Biomanufacturing & Bioenergy (E3B): Metals in Biology funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3389/fphar.2021.660490

PubMed Identifier: 34421587

Publication URI: http://europepmc.org/abstract/MED/34421587

Type: Journal Article/Review

Volume: 12

Parent Publication: Frontiers in pharmacology

ISSN: 1663-9812